Todd Wisialowski
Pfizer (United States)(US)PRX Research
Publications by Year
Research Areas
Cardiac electrophysiology and arrhythmias, Ion channel regulation and function, Computational Drug Discovery Methods, Receptor Mechanisms and Signaling, Adipose Tissue and Metabolism
Most-Cited Works
- → Dynamic Beat-to-Beat Modeling of the QT-RR Interval Relationship: Analysis of QT Prolongation during Alterations of Autonomic State versus Human Ether a-go-go-Related Gene Inhibition(2004)118 cited
- → General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy(2019)108 cited
- → Phase Shifting of Circadian Rhythms and Depression of Neuronal Activity in the Rat Suprachiasmatic Nucleus by Neuropeptide Y: Mediation by Different Receptor Subtypes(1998)106 cited
- → Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective(2020)94 cited
- → Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig(2004)71 cited
- → Can non‐clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium(2017)66 cited
- → A Reexamination of the Role of GABA in the Mammalian Suprachiasmatic Nucleus(1999)61 cited
- → Adrenalectomy reduces neuropeptide Y–induced insulin release and NPY receptor expression in the rat ventromedial hypothalamus(2000)56 cited
- → Differentiation of Arrhythmia Risk of the Antibacterials Moxifloxacin, Erythromycin, and Telithromycin Based on Analysis of Monophasic Action Potential Duration Alternans and Cardiac Instability(2006)51 cited
- → QT Prolongation Modifies Dynamic Restitution and Hysteresis of the Beat-to-Beat QT-TQ Interval Relationship during Normal Sinus Rhythm under Varying States of Repolarization(2006)50 cited